- Home
- ATCH vs XXII Comparison
ATCH vs XXII Comparison
Compare ATCH & XXII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATCH
- XXII
- Stock Information
- Founded
- ATCH 2022
- XXII 1998
- Country
- ATCH United States
- XXII United States
- Employees
- ATCH N/A
- XXII N/A
- Industry
- ATCH
- XXII Medicinal Chemicals and Botanical Products
- Sector
- ATCH
- XXII Health Care
- Exchange
- ATCH Nasdaq
- XXII Nasdaq
- Market Cap
- ATCH 3.7M
- XXII 4.0M
- IPO Year
- ATCH N/A
- XXII N/A
- Fundamental
- Price
- ATCH $0.17
- XXII $0.09
- Analyst Decision
- ATCH
- XXII
- Analyst Count
- ATCH 0
- XXII 0
- Target Price
- ATCH N/A
- XXII N/A
- AVG Volume (30 Days)
- ATCH 11.0M
- XXII 9.6M
- Earning Date
- ATCH 11-29-2024
- XXII 11-12-2024
- Dividend Yield
- ATCH N/A
- XXII N/A
- EPS Growth
- ATCH N/A
- XXII N/A
- EPS
- ATCH 0.04
- XXII N/A
- Revenue
- ATCH N/A
- XXII $9,918,000.00
- Revenue This Year
- ATCH N/A
- XXII $56.94
- Revenue Next Year
- ATCH N/A
- XXII $2.98
- P/E Ratio
- ATCH $4.04
- XXII $0.03
- Revenue Growth
- ATCH N/A
- XXII N/A
- 52 Week Low
- ATCH $0.12
- XXII $0.09
- 52 Week High
- ATCH $10.26
- XXII $5.28
- Technical
- Relative Strength Index (RSI)
- ATCH 44.35
- XXII 31.38
- Support Level
- ATCH $0.17
- XXII $0.09
- Resistance Level
- ATCH $0.26
- XXII $0.13
- Average True Range (ATR)
- ATCH 0.04
- XXII 0.01
- MACD
- ATCH 0.00
- XXII 0.01
- Stochastic Oscillator
- ATCH 12.92
- XXII 10.51
About ATCH AtlasClear Holdings Inc. Common Stock
AtlasClear Holdings Inc is a fintech company. Its goal is to build a cutting-edge technology-enabled financial services firm that would create a more efficient platform for trading, clearing, settlement, and banking of evolving and innovative financial products with a focus on financial services firms. It is a fintech-driven business-to-business platform that expects to power innovation in fintech, investing, and trading. The company believes it is positioned to provide a modern, mission-critical suite of solutions to its clients, enabling them to reduce their transaction costs and compete more effectively in their businesses.
About XXII 22nd Century Group Inc.
22nd Century Group Inc is a United States-based biotechnology company focused on utilizing alkaloid plant technologies to improve health and wellness with reduced nicotine tobacco, and hemp/cannabis. It has one operating segment; The tobacco segment is engaged in commercializing its proprietary VLNC tobacco plants and cigarette products, which contain nicotine than conventional tobacco and cigarettes, and research cigarettes sold under the brand name SPECTRUM. It derives a majority of its revenue from the tobacco segment.